FDA-Registered vs. FDA-Approved: What the Difference Means

Few distinctions cause more confusion in regenerative research than \”FDA-registered\” versus \”FDA-approved.\” They sound similar and mean very different things. Getting this right protects both customers and suppliers. This explainer is provided for educational and research purposes only.

FDA registration: an establishment step

When a facility is \”FDA-registered,\” it has listed its establishment with the agency, as certain facilities are required to do. Registration is an administrative step. It does not mean the FDA has reviewed, tested, endorsed, or approved any specific product made there.

FDA approval: a product authorization

FDA approval (or clearance) is a separate, rigorous process in which the agency evaluates a specific product’s safety and effectiveness for a specific use. Research-use-only MSC exosomes are not FDA-approved as treatments.

Why the difference matters

Marketing that implies facility registration equals product approval is misleading and carries regulatory risk. A trustworthy supplier states plainly that a cGMP-aligned, registered facility describes its quality approach — not FDA endorsement of the product.

The takeaway

Registered describes the facility. Approved describes a product. Confusing the two — deliberately or not — is exactly what honest labeling avoids.

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease and are supplied for research use only. This content is for educational and informational purposes and does not constitute medical advice.